NASDAQ:SYBX

Synlogic (SYBX) Stock Price, News & Analysis

Synlogic logo
$0.98 0.00 (0.00%)
As of 11/18/2026 11:03 AM Eastern

About Synlogic Stock (NASDAQ:SYBX)

Advanced

Key Stats

Today's Range
$0.98
▼
$0.98
50-Day Range
$0.96
▼
$1.22
52-Week Range
$0.54
▼
$1.73
Volume
1,002 shs
Average Volume
61,109 shs
Market Capitalization
$12.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Synlogic is a biotechnology company that has focused on developing “synthetic biotics”—engineered bacteria designed to perform therapeutic functions in the body. Its approach uses synthetic biology to modify microbes so they can produce or consume specific substances, with the aim of treating disease.

The company’s research has centered on rare metabolic disorders, including phenylketonuria (PKU) and homocystinuria. Its investigational programs were designed to help break down compounds that build up in people with these conditions. Synlogic has not been known for marketed medicines; its work has been primarily in research and clinical development.

Founded in 2013 as a spinout from the Massachusetts Institute of Technology, Synlogic has been based in Cambridge, Massachusetts. Its programs and platform have been directed mainly toward the development of treatments for patients with metabolic diseases.

AI Generated. May Contain Errors.

Receive SYBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Synlogic and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SYBX Stock News Headlines

Synlogic (SYBX) Set to Post Earnings on Wednesday
CFA: Bank of America Said THIS
On January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savings account… The digital dollar is inevitable. Think about what this means... When the digital dollar goes live, every dollar you saved could suddenly be trackable at the transaction level. Imagine the worst case scenario: You’re now subject to new digital withdrawal limits and spending restrictions. Your account can be frozen remotely without court approval. But here's what Bank of America didn't say: There's still a way to protect your wealth before this digital prison locks. While everyone else gets trapped in the digital system, my research team has been positioning members outside that reach… completely under their own control. No government tracking. No withdrawal limits. No remote freezing.tc pixel
Synlogic Challenges Nasdaq Delisting Notice
We Think Synlogic (NASDAQ:SYBX) Can Afford To Drive Business Growth
See More Headlines

SYBX Stock Analysis - Frequently Asked Questions

Synlogic's stock was trading at $1.12 at the beginning of the year. Since then, SYBX stock has decreased by 12.2% and is now trading at $0.9836.

Synlogic, Inc. (NASDAQ:SYBX) issued its earnings results on Tuesday, November, 10th. The biotechnology company reported ($0.31) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($5.80) by $5.49.

Shares of Synlogic reverse split on Thursday, September 28th 2023.The 1-15 reverse split was announced on Thursday, September 28th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Synlogic (SYBX) raised $88 million in an initial public offering on Wednesday, September 30th 2015. The company issued 6,250,000 shares at a price of $13.00-$15.00 per share.

Shares of SYBX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Synlogic investors own include NIO (NIO), Advanced Micro Devices (AMD), NVIDIA (NVDA), Block (XYZ), Tesla (TSLA), SCYNEXIS (SCYX) and Nokia (NOK).

Company Calendar

Last Earnings
11/10/2026
Today
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:SYBX
CIK
1527599
Employees
80
Year Founded
2013

Profitability

EPS (Trailing Twelve Months)
($0.18)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$23.36 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-26.47%
Return on Assets
-18.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.65
Quick Ratio
2.65

Sales & Book Value

Annual Sales
$8 thousand
Price / Sales
1,506.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.09 per share
Price / Book
0.90

Miscellaneous

Outstanding Shares
12,249,000
Free Float
11,392,000
Market Cap
$12.05 million
Optionable
No Data
Beta
0.70

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NASDAQ:SYBX) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners